NCT06494813View on ClinicalTrials.gov

Biochemical Role of Matrix Metalloproteinase -9 in Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

December 15, 2024

Conditions
Rheumatoid Arthritis
Interventions
DIAGNOSTIC_TEST

conventional pcr

conventional pcr to study matrix metalloproteinase -9 gene polymorphismin rheumatoid arthritis

Trial Locations (1)

Unknown

Sohag University hospitals, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06494813 - Biochemical Role of Matrix Metalloproteinase -9 in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter